Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

Autor: Béguelin, Charles, Suter, Annatina, Bernasconi, Enos, Fehr, Jan, Kovari, Helen, Bucher, Heiner C, Stoeckle, Marcel, Cavassini, Mathias, Rougemont, Mathieu, Schmid, Patrick, Wandeler, Gilles, Rauch, Andri, Swiss HIV Cohort Study

Publikováno v: Liver international, vol. 38, no. 3, pp. 424-431
Liver International, Vol. 38, No 3 (2018) pp. 424-431

BACKGROUND & AIMS Hepatitis C virus (HCV) therapies with interferon-free second-generation direct-acting antiviral agents (DAAs) are highly effective and well tolerated. They have the potential to increase treatment eligibility and efficacy in HIV-in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c6f6b8fac0920e3465a075cd2564e7
https://doi.org/10.1111/liv.13528

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared

Autor: Wandeler Gilles, Mulenga Lloyd, Vinikoor Michael J, Kovari Helen, Battegay Manuel, Calmy Alexandra, Cavassini Matthias, Bernasconi Enos, Schmid Patrick, Bolton-Moore Carolyn, Sinkala Edford, Chi Benjamin H, Egger Matthias, Rauch Andri

Publikováno v: International Journal of Infectious Diseases, Vol. 51 (2016) pp. 97-102
Wandeler, Gilles; Mulenga, Lloyd; Vinikoor, Michael J; Kovari, Helen; Battegay, Manuel; Calmy, Alexandra; Cavassini, Matthias; Bernasconi, Enos; Schmid, Patrick; Bolton-Moore, Carolyn; Sinkala, Edford; Chi, Benjamin H; Egger, Matthias; Rauch, Andri (2016). Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. International journal of infectious diseases, 51, pp. 97-102. Elsevier 10.1016/j.ijid.2016.08.028
International Journal of Infectious Diseases, Vol 51, Iss C, Pp 97-102 (2016)
International journal of infectious diseases : IJID : official publication of the International Soci
International journal of infectious diseases, vol. 51, pp. 97-102

OBJECTIVE To examine the association between hepatitis B virus (HBV) infection and liver fibrosis in HIV-infected patients in Zambia and Switzerland. METHODS HIV-infected adults starting antiretroviral therapy in two clinics in Zambia and Switzerland

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c13cddc0a04701f929341e9616435dd3
https://archive-ouverte.unige.ch/unige:89545

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Autor: John G. McHutchison, Stanislas Pol, Dominique Larrey, Albert Tran, Sophie Metivier, Patrick Marcellin, Victor de Ledinghen, Lawrence Serfaty, François Habersetzer, Vlad Ratziu, Phillip S. Pang, William T. Symonds, Jean-Didier Grangé, Robert H. Hyland, Laurent Alric, Vincent Leroy, Véronique Loustaud-Ratti, Jean-Pierre Bronowicki, Deyuan Jiang, Philippe Mathurin, Dominique Guyader, Marc Bourlière, Fabien Zoulim, Christophe Hézode, Armand Abergel, G. Mani Subramanian, Brian P. Doehle

Publikováno v: The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
The Lancet Infectious Diseases, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2015, 15 (4), pp.397-404. 〈10.1016/S1473-3099(15)70050-2〉

Summary Background Patients with cirrhosis resulting from chronic hepatitis C virus (HCV) infection are at risk of life-threatening complications, but consistently achieve lower sustained virological response (SVR) than patients without cirrhosis, es

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb0f598ef5688abbcb07c6ae6c6f530
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01134440

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3

Autor: Gilles Mentha, Pierre-Jean Malé, Emiliano Giostra, Karim Abid, Bettina Borisch, Francesco Negro, Antoine Hadengue, Jean-Pierre Zarski, Rafael Quadri, Laura Rubbia-Brandt, Laurent Spahr

Publikováno v: Journal of Hepatology, Vol. 33, No 1 (2000) pp. 106-15
Journal of hepatology, vol. 33, no. 1, pp. 106-115

Background/Aims: Patients infected with the hepatitis C virus (HCV) often have liver steatosis, suggesting the possibility of a viral cytopathic effect. The aim of this study was to correlate the occurrence and severity of liver steatosis with HCV RN

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab364d77f4d49d9dd5da704fc46b974
https://doi.org/10.1016/s0168-8278(00)80166-x

Le variant de l'Adiponutrine I148M est un facteur de risque de cancer du foie associé au VHC chez les patients nord-africains

Autor: Ezzikouri, Sayeh, Alaoui, Rhimou, Tazi, Sana, Nadir, Salwa, Elmdaghri, Naima, Pineau, Pascal, Benjelloun, Soumaya

Publikováno v: Infection, Genetics and Evolution
Infection, Genetics and Evolution, Elsevier, 2014, 21, pp.179-183. ⟨10.1016/j.meegid.2013.11.005⟩
Infection, Genetics and Evolution, 2014, 21, pp.179-183. ⟨10.1016/j.meegid.2013.11.005⟩

International audience; Recent reports revealed an association between variation in the PNPLA3 gene and alcohol-induced hepatocellular carcinoma among Europeans. We have assessed whether the PNPLA3 rs738409 (I148M) polymorphism may also affect the re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9aac67f28c1fc8d564c44316a7792f27
https://hal-pasteur.archives-ouvertes.fr/pasteur-02863287